MEDIFAST INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $385.8M | $602.5M | $1.1B | $1.6B | $1.5B |
| Gross profit | $275.2M | $444.6M | $775.9M | $1.1B | $1.1B |
| Operating income | -$14.2M | $2.9M | $126.4M | $184.8M | $216.2M |
| Cost of revenue | $110.6M | $157.8M | $296.2M | $458.2M | $398.5M |
| Cash from operations | $6.9M | $24.5M | $147.7M | $194.6M | $94.5M |
| Capital expenditure | $5.6M | $7.5M | $6.5M | $16.7M | $34.2M |
| Free cash flow | $1.2M | $17.0M | $141.2M | $177.9M | $60.3M |
| Share repurchases | $0 | $0 | $3.6M | $126.4M | $56.0M |
| Total assets | $248.0M | $284.2M | $309.9M | $316.2M | $398.3M |
| Total liabilities | $49.1M | $74.1M | $108.4M | $161.2M | $195.9M |
Shares outstanding 11.1M · Free float 72.1%
Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.